The Fly

Keurig Dr Pepper price target raised to $41 from $40 at JPMorgan

JPMorgan analyst Andrea Teixeira raised the firm’s price target on Keurig Dr Pepper to $41 from $40 and keeps an Overweight rating on the shares. The analyst sees a favorable risk/reward on the shares, saying the company has set the bar lower and is baking in a fair amount of conservatism for 2023 given macro uncertainty and a new CFO joining. JPMorgan views Keurig Dr Pepper’s valuation as "compelling" at current share levels.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on KDP:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More